523 related articles for article (PubMed ID: 28758324)
1. Surgery and survival in birth cohorts with severe haemophilia and differences in access to replacement therapy: The Malmö experience.
Osooli M; Steen Carlsson K; Astermark J; Berntorp E
Haemophilia; 2017 Sep; 23(5):e403-e408. PubMed ID: 28758324
[TBL] [Abstract][Full Text] [Related]
2. Current situation of regular replacement therapy (prophylaxis) for haemophilia in Japan.
Taki M; Shirahata A
Haemophilia; 2009 Jan; 15(1):78-82. PubMed ID: 18700841
[TBL] [Abstract][Full Text] [Related]
3. The overall effectiveness of prophylaxis in severe haemophilia.
Panicker J; Warrier I; Thomas R; Lusher JM
Haemophilia; 2003 May; 9(3):272-8. PubMed ID: 12694517
[TBL] [Abstract][Full Text] [Related]
4. Haemophilia prophylaxis in young patients--a long-term follow-up.
Löfqvist T; Nilsson IM; Berntorp E; Pettersson H
J Intern Med; 1997 May; 241(5):395-400. PubMed ID: 9183307
[TBL] [Abstract][Full Text] [Related]
5. [Prevention of joint damage in hemophilic children with early prophylaxis].
Kreuz W; Escuriola Ettingshausen C; Funk M; Pons S; Schmidt H; Kornhuber B
Orthopade; 1999 Apr; 28(4):341-6. PubMed ID: 10335528
[TBL] [Abstract][Full Text] [Related]
6. Treatment outcomes in persons with severe haemophilia B in the Nordic region: The B-NORD study.
Kihlberg K; Baghaei F; Bruzelius M; Funding E; Andre Holme P; Lassila R; Nummi V; Ranta S; Osooli M; Berntorp E; Astermark J
Haemophilia; 2021 May; 27(3):366-374. PubMed ID: 33780113
[TBL] [Abstract][Full Text] [Related]
7. The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey.
Biss TT; Chan AK; Blanchette VS; Iwenofu LN; McLimont M; Carcao MD; ;
Haemophilia; 2008 Sep; 14(5):923-30. PubMed ID: 18637844
[TBL] [Abstract][Full Text] [Related]
8. On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome.
Steen Carlsson K; Höjgård S; Glomstein A; Lethagen S; Schulman S; Tengborn L; Lindgren A; Berntorp E; Lindgren B
Haemophilia; 2003 Sep; 9(5):555-66. PubMed ID: 14511294
[TBL] [Abstract][Full Text] [Related]
9. Optimizing factor prophylaxis for the haemophilia population: where do we stand?
Blanchette VS; Manco-Johnson M; Santagostino E; Ljung R
Haemophilia; 2004 Oct; 10 Suppl 4():97-104. PubMed ID: 15479380
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis for severe haemophilia: clinical and economical issues.
Fischer K; Van Den Berg M
Haemophilia; 2003 Jul; 9(4):376-81. PubMed ID: 12828671
[TBL] [Abstract][Full Text] [Related]
11. A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia.
Ahnström J; Berntorp E; Lindvall K; Björkman S
Haemophilia; 2004 Nov; 10(6):689-97. PubMed ID: 15569163
[TBL] [Abstract][Full Text] [Related]
12. Variability in clinical phenotype of severe haemophilia: the role of the first joint bleed.
van Dijk K; Fischer K; van der Bom JG; Grobbee DE; van den Berg HM
Haemophilia; 2005 Sep; 11(5):438-43. PubMed ID: 16128885
[TBL] [Abstract][Full Text] [Related]
13. Similar bleeding phenotype in young children with haemophilia A or B: a cohort study.
Clausen N; Petrini P; Claeyssens-Donadel S; Gouw SC; Liesner R;
Haemophilia; 2014 Nov; 20(6):747-55. PubMed ID: 24893572
[TBL] [Abstract][Full Text] [Related]
14. Haemophilia treatment in the United Kingdom from 1969 to 1974.
Biggs R
Br J Haematol; 1977 Apr; 35(4):487-504. PubMed ID: 871406
[TBL] [Abstract][Full Text] [Related]
15. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B.
Nilsson IM; Berntorp E; Löfqvist T; Pettersson H
J Intern Med; 1992 Jul; 232(1):25-32. PubMed ID: 1640190
[TBL] [Abstract][Full Text] [Related]
16. Low-dose tertiary prophylactic therapy reduces total number of bleeds and improves the ability to perform activities of daily living in adults with severe haemophilia A: a single-centre experience from Beijing.
Hua B; Lian X; Li K; Lee A; Poon MC; Zhao Y
Blood Coagul Fibrinolysis; 2016 Mar; 27(2):136-40. PubMed ID: 26258677
[TBL] [Abstract][Full Text] [Related]
17. [French guidelines. Long-term prophylaxis for severe haemophilia A and B children to prevent haemophiliac arthropathy].
Meunier S; Trossaërt M; Berger C; Borel-Derlon A; Dirat G; Donadel-Claeyssens S; Assolant AD; Guérois C; Lutz P; Rafowicz A; Rothschild C; Chambost H;
Arch Pediatr; 2009 Dec; 16(12):1571-8. PubMed ID: 19960603
[TBL] [Abstract][Full Text] [Related]
18. Comparative burden of arthropathy in mild haemophilia: a register-based study in Sweden.
Osooli M; Lövdahl S; Steen Carlsson K; Knobe K; Baghaei F; Holmström M; Astermark J; Berntorp E
Haemophilia; 2017 Mar; 23(2):e79-e86. PubMed ID: 28155262
[TBL] [Abstract][Full Text] [Related]
19. Management of haemophilia in Sweden.
Nilsson IM
Thromb Haemost; 1976 Jun; 35(3):510-21. PubMed ID: 989956
[TBL] [Abstract][Full Text] [Related]
20. Severe and moderate haemophilia A and B in US females.
Di Michele DM; Gibb C; Lefkowitz JM; Ni Q; Gerber LM; Ganguly A
Haemophilia; 2014 Mar; 20(2):e136-43. PubMed ID: 24533955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
